Gabelli Funds’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-44,083
| Closed | -$2.74M | – | 1337 |
|
|
2020
Q4 | $2.74M | Sell |
44,083
-8,015
| -15% | -$497K | 0.02% | 628 |
|
|
2020
Q3 | $3.1M | Buy |
52,098
+17,633
| +51% | +$1.05M | 0.02% | 559 |
|
|
2020
Q2 | $2.41M | Sell |
34,465
-42,162
| -55% | -$2.94M | 0.02% | 614 |
|
|
2020
Q1 | $3.48M | Sell |
76,627
-16,030
| -17% | -$727K | 0.03% | 497 |
|
|
2019
Q4 | $6.03M | Hold |
92,657
| – | – | 0.04% | 464 |
|
|
2019
Q3 | $5.75M | Buy |
92,657
+802
| +0.9% | +$49.8K | 0.04% | 470 |
|
|
2019
Q2 | $6.54M | Hold |
91,855
| – | – | 0.04% | 449 |
|
|
2019
Q1 | $7.2M | Buy |
91,855
+26,933
| +41% | +$2.11M | 0.05% | 429 |
|
|
2018
Q4 | $5.5M | Buy |
64,922
+37,671
| +138% | +$3.19M | 0.04% | 480 |
|
|
2018
Q3 | $4.67M | Hold |
27,251
| – | – | 0.03% | 589 |
|
|
2018
Q2 | $3.52M | Sell |
27,251
-16,952
| -38% | -$2.19M | 0.02% | 653 |
|
|
2018
Q1 | $4.55M | Sell |
44,203
-7,213
| -14% | -$743K | 0.03% | 577 |
|
|
2017
Q4 | $4.39M | Sell |
51,416
-2,405
| -4% | -$205K | 0.03% | 596 |
|
|
2017
Q3 | $4.57M | Sell |
53,821
-8,015
| -13% | -$681K | 0.03% | 586 |
|
|
2017
Q2 | $4.68M | Sell |
61,836
-8,015
| -11% | -$607K | 0.03% | 575 |
|
|
2017
Q1 | $4.61M | Buy |
69,851
+36,188
| +108% | +$2.39M | 0.03% | 582 |
|
|
2016
Q4 | $2.13M | Buy |
+33,663
| New | +$2.13M | 0.01% | 768 |
|